<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39386074</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>11</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2057-1577</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>1</Issue><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>Virus evolution</Title><ISOAbbreviation>Virus Evol</ISOAbbreviation></Journal><ArticleTitle>SARS-CoV-2 variant replacement constrains vaccine-specific viral diversification.</ArticleTitle><Pagination><StartPage>veae071</StartPage><MedlinePgn>veae071</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">veae071</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1093/ve/veae071</ELocationID><Abstract><AbstractText>Coronavirus disease 2019 (COVID-19) vaccine breakthrough infections have been important for all circulating severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant periods, but the contribution of vaccine-specific SARS-CoV-2 viral diversification to vaccine failure remains unclear. This study analyzed 595 SARS-CoV-2 sequences collected from the Military Health System beneficiaries between December 2020 and April 2022 to investigate the impact of vaccination on viral diversity. By comparing sequences based on the vaccination status of the participant, we found limited evidence indicating that vaccination was associated with increased viral diversity in the SARS-CoV-2 spike, and we show little to no evidence of a substantial sieve effect within major variants; rather, we show that rapid variant replacement constrained intragenotype COVID-19 vaccine strain immune escape. These data suggest that, during past and perhaps future periods of rapid SARS-CoV-2 variant replacement, vaccine-mediated effects were subsumed with other drivers of viral diversity due to the massive scale of infections and vaccinations that occurred in a short time frame. However, our results also highlight some limitations of using sieve analysis methods outside of placebo-controlled clinical trials.</AbstractText><CopyrightInformation>© The Author(s) 2024. Published by Oxford University Press.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Dearlove</LastName><ForeName>Bethany L</ForeName><Initials>BL</Initials><Identifier Source="ORCID">0000-0003-3653-4592</Identifier><AffiliationInfo><Affiliation>US Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fries</LastName><ForeName>Anthony C</ForeName><Initials>AC</Initials><Identifier Source="ORCID">0000-0001-7556-1353</Identifier><AffiliationInfo><Affiliation>The Applied Technology and Genomics (PHT) Division, US Air Force School of Aerospace Medicine, 2510 5th St, Dayton, OH 45433, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Epsi</LastName><ForeName>Nusrat J</ForeName><Initials>NJ</Initials><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Richard</LastName><ForeName>Stephanie A</ForeName><Initials>SA</Initials><Identifier Source="ORCID">0000-0002-0530-384X</Identifier><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ganesan</LastName><ForeName>Anuradha</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huprikar</LastName><ForeName>Nikhil</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Walter Reed National Military Medical Center, 8901 Rockville Pike, Bethesda, MD 20889, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lindholm</LastName><ForeName>David A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0001-5428-7404</Identifier><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brooke Army Medical Center, 3551 Roger Brooke Drive, San Antonio, TX 78234, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mende</LastName><ForeName>Katrin</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Brooke Army Medical Center, 3551 Roger Brooke Drive, San Antonio, TX 78234, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Rhonda E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Madigan Army Medical Center, 9040 Jackson Avenue, Tacoma, WA 98431, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Christopher</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Madigan Army Medical Center, 9040 Jackson Avenue, Tacoma, WA 98431, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Hongjun</ForeName><Initials>H</Initials><Identifier Source="ORCID">0000-0002-3501-3974</Identifier><AffiliationInfo><Affiliation>US Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larson</LastName><ForeName>Derek T</ForeName><Initials>DT</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Alexander T. Augusta Military Medical Center, 9300 DeWitt Loop, Fort Belvoir, VA 22060, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ewers</LastName><ForeName>Evan C</ForeName><Initials>EC</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Alexander T. Augusta Military Medical Center, 9300 DeWitt Loop, Fort Belvoir, VA 22060, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lalani</LastName><ForeName>Tahaniyat</ForeName><Initials>T</Initials><Identifier Source="ORCID">0000-0002-9361-2991</Identifier><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Infectious Diseases, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Smith</LastName><ForeName>Alfred G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, Naval Medical Center Portsmouth, 620 John Paul Jones Circle, Portsmouth, VA 23708, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Berjohn</LastName><ForeName>Catherine M</ForeName><Initials>CM</Initials><Identifier Source="ORCID">0000-0001-5655-8183</Identifier><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Diseases and Internal Medicine, Naval Medical Center San Diego, 34800 Bob Wilson Drive, San Diego, CA 92134, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maves</LastName><ForeName>Ryan C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Sections of Infectious Diseases and Critical Care Medicine, Wake Forest University School of Medicine, Medical Center Boulevard, Winston-Salem, NC 27157, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Jones</LastName><ForeName>Milissa U</ForeName><Initials>MU</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saunders</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Medicine, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maldonado</LastName><ForeName>Carlos J</ForeName><Initials>CJ</Initials><Identifier Source="ORCID">0000-0002-7484-9942</Identifier><AffiliationInfo><Affiliation>Department of Clinical Investigation, Womack Army Medical Center, 2817 Rock Merritt Avenue, Fort Liberty, NC, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mody</LastName><ForeName>Rupal M</ForeName><Initials>RM</Initials><AffiliationInfo><Affiliation>Division of Infectious Diseases, William Beaumont Army Medical Center, 18511 Highlander Medics Street, El Paso, TX 79918, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bazan</LastName><ForeName>Samantha E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Primary Care, Carl R. Darnall Army Medical Center, 590 Medical Center Road, Fort Cavazos, TX 76544, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tribble</LastName><ForeName>David R</ForeName><Initials>DR</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burgess</LastName><ForeName>Timothy</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Simons</LastName><ForeName>Mark P</ForeName><Initials>MP</Initials><Identifier Source="ORCID">0000-0002-4316-9709</Identifier><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agan</LastName><ForeName>Brian K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pollett</LastName><ForeName>Simon D</ForeName><Initials>SD</Initials><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious Disease Clinical Research Program, Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, 4301 Jones Bridge Road, Bethesda, MD 20814, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rolland</LastName><ForeName>Morgane</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0003-3650-8490</Identifier><AffiliationInfo><Affiliation>US Military HIV Research Program, Walter Reed Army Institute of Research, 503 Robert Grant Avenue, Silver Spring, MD 20910, United States.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Henry M Jackson Foundation for the Advancement of Military Medicine, Inc., 6720A Rockledge Drive, Bethesda, MD 20817, United States.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Virus Evol</MedlineTA><NlmUniqueID>101664675</NlmUniqueID><ISSNLinking>2057-1577</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">sieve analysis</Keyword><Keyword MajorTopicYN="N">vaccine breakthrough</Keyword><Keyword MajorTopicYN="N">variants</Keyword></KeywordList><CoiStatement>The views expressed are those of the authors and do not reflect the official policy of the Uniformed Services University of the Health Sciences (USUHS), Department of the Army, Department of the Navy, the Department of the Air Force, the Department of Defense or the US Government, and the Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc. (HJF). The investigators have adhered to the policies for protection of human subjects as prescribed in 45 CFR 46. Drs Berjohn, Fries, Smith, Mody, Huprikar, Lindholm, Jones, Larson, Ewers; Ms Bazan; and Drs Saunders, Maldonado, Simons, Tribble, and Burgess are service members or employees of the US Government. This work was prepared as part of their official duties. Title 17 USC §105 provides that “Copyright protection under this title is not available for any work of the United States Government.” Title 17 USC §101 defines a US Government work as a work prepared by a military service member or employee of the US Government as part of that person’s official duties.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>11</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>5</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>10</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>10</Day><Hour>4</Hour><Minute>59</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39386074</ArticleId><ArticleId IdType="pmc">PMC11463026</ArticleId><ArticleId IdType="doi">10.1093/ve/veae071</ArticleId><ArticleId IdType="pii">veae071</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Cao L, Lou J, Chan SY. et al. Rapid evaluation of COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 variants by analysis of genetic distance. Nat Med 2022;28:1715–22. doi: 10.1038/s41591-022-01877-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01877-1</ArticleId><ArticleId IdType="pmc">PMC9388371</ArticleId><ArticleId IdType="pubmed">35710987</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao Y, Jian F, Wang J. et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature 2023;614:521–29. doi: 10.1038/s41586-022-05644-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-022-05644-7</ArticleId><ArticleId IdType="pmc">PMC9931576</ArticleId><ArticleId IdType="pubmed">36535326</ArticleId></ArticleIdList></Reference><Reference><Citation>
CDC . COVID-19 Vaccination Age and Sex Trends in the United States, National and Jurisdictional. 2023. https://data.cdc.gov/Vaccinations/COVID-19-Vaccination-Age-and-Sex-Trends-in-the-Uni/5i5k-6cmh/about_data (19 February 2024, date last accessed).</Citation></Reference><Reference><Citation>Corey L, Beyrer C, Cohen MS. et al. SARS-CoV-2 variants in immunosuppressed individuals. N Engl J Med 2021;385:562–66. doi: 10.1056/NEJMsb2104756</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMsb2104756</ArticleId><ArticleId IdType="pmc">PMC8494465</ArticleId><ArticleId IdType="pubmed">34347959</ArticleId></ArticleIdList></Reference><Reference><Citation>Edlefsen PT, Rolland M, Hertz T. et al. Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial. PLoS Comput Biol 2015;11:1–37. doi: 10.1371/journal.pcbi.1003973</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pcbi.1003973</ArticleId><ArticleId IdType="pmc">PMC4315437</ArticleId><ArticleId IdType="pubmed">25646817</ArticleId></ArticleIdList></Reference><Reference><Citation>Epsi NJ, Powers JH, Lindholm DA. et al. A machine learning approach identifies distinct early-symptom cluster phenotypes which correlate with hospitalization, failure to return to activities, and prolonged COVID-19 symptoms. PLoS One 2023a;18:e0281272. doi: 10.1371/journal.pone.0281272</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0281272</ArticleId><ArticleId IdType="pmc">PMC9910657</ArticleId><ArticleId IdType="pubmed">36757946</ArticleId></ArticleIdList></Reference><Reference><Citation>Epsi NJ, Richard SA, Lindholm DA. et al. Understanding “Hybrid Immunity”: comparison and predictors of humoral immune responses to severe acute respiratory syndrome coronavirus 2 infection (SARS-CoV-2) and coronavirus disease 2019 (COVID-19) vaccines. Clin Infect Dis 2023b;76:e439–49. doi: 10.1093/cid/ciac392</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciac392</ArticleId><ArticleId IdType="pmc">PMC9213853</ArticleId><ArticleId IdType="pubmed">35608504</ArticleId></ArticleIdList></Reference><Reference><Citation>Feikin DR, Higdon MM, Abu-Raddad LJ. et al. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet 2022;399:924–44. doi: 10.1016/S0140-6736(22)00152-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(22)00152-0</ArticleId><ArticleId IdType="pmc">PMC8863502</ArticleId><ArticleId IdType="pubmed">35202601</ArticleId></ArticleIdList></Reference><Reference><Citation>Freed NE, Vlková M, Faisal MB. et al. Rapid and inexpensive whole-genome sequencing of SARS-CoV-2 using 1200 bp tiled amplicons and Oxford Nanopore Rapid Barcoding. Biol Methods Protoc 2020;5:bpaa014. doi: 10.1093/biomethods/bpaa014</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/biomethods/bpaa014</ArticleId><ArticleId IdType="pmc">PMC7454405</ArticleId><ArticleId IdType="pubmed">33029559</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert PB. A modified false discovery rate multiple-comparisons procedure for discrete data, applied to human immunodeficiency virus genetics. J R Stat Soc Ser C Appl Stat 2005;54:143–58. doi: 10.1111/j.1467-9876.2005.00475.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1467-9876.2005.00475.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilbert PB, Wu C, Jobes DV. Genome scanning tests for comparing amino acid sequences between groups. Biometrics 2008;64:198–207. doi: 10.1111/j.1541-0420.2007.00845.x</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1541-0420.2007.00845.x</ArticleId><ArticleId IdType="pubmed">17608781</ArticleId></ArticleIdList></Reference><Reference><Citation>Haas EJ, Angulo FJ, McLaughlin JM. et al. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data. Lancet 2021;397:1819–29. doi: 10.1016/S0140-6736(21)00947-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00947-8</ArticleId><ArticleId IdType="pmc">PMC8099315</ArticleId><ArticleId IdType="pubmed">33964222</ArticleId></ArticleIdList></Reference><Reference><Citation>Hacisuleyman E, Hale C, Saito Y. et al. Vaccine breakthrough infections with SARS-CoV-2 variants. N Engl J Med 2021;384:2212–18. doi: 10.1056/nejmoa2105000</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/nejmoa2105000</ArticleId><ArticleId IdType="pmc">PMC8117968</ArticleId><ArticleId IdType="pubmed">33882219</ArticleId></ArticleIdList></Reference><Reference><Citation>Harari S, Tahor M, Rutsinsky N. et al. Drivers of adaptive evolution during chronic SARS-CoV-2 infections. Nat Med 2022;28:1501–08. doi: 10.1038/s41591-022-01882-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01882-4</ArticleId><ArticleId IdType="pmc">PMC9307477</ArticleId><ArticleId IdType="pubmed">35725921</ArticleId></ArticleIdList></Reference><Reference><Citation>Juraska M, Bai H, DeCamp AC. et al. Prevention efficacy of the broadly neutralizing antibody VRC01 depends on HIV-1 envelope sequence features. Proc Natl Acad Sci USA 2024;121:e2308942121. doi: 10.1073/pnas.2308942121</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2308942121</ArticleId><ArticleId IdType="pmc">PMC10823214</ArticleId><ArticleId IdType="pubmed">38241441</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalyaanamoorthy S, Minh BQ, Wong TKF. et al. ModelFinder: fast model selection for accurate phylogenetic estimates. Nat Methods 2017;14:587–89. doi: 10.1038/nmeth.4285</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4285</ArticleId><ArticleId IdType="pmc">PMC5453245</ArticleId><ArticleId IdType="pubmed">28481363</ArticleId></ArticleIdList></Reference><Reference><Citation>Katoh K, and Standley DM. A simple method to control over-alignment in the MAFFT multiple sequence alignment program. Bioinformatics 2016;32:1933–42. doi: 10.1093/bioinformatics/btw108</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw108</ArticleId><ArticleId IdType="pmc">PMC4920119</ArticleId><ArticleId IdType="pubmed">27153688</ArticleId></ArticleIdList></Reference><Reference><Citation>Khare S, Gurry C, Freitas L. et al. GISAID’s role in pandemic response. China CDC Wkly 2021;3:1049–51. doi: 10.46234/ccdcw2021.255</Citation><ArticleIdList><ArticleId IdType="doi">10.46234/ccdcw2021.255</ArticleId><ArticleId IdType="pmc">PMC8668406</ArticleId><ArticleId IdType="pubmed">34934514</ArticleId></ArticleIdList></Reference><Reference><Citation>Lusvarghi S, Pollett SD, Nath Neerukonda S. et al. SARS-CoV-2 BA.1 variant is neutralized by vaccine booster-elicited serum but evades most convalescent serum and therapeutic antibodies. Sci Trans Med 2022;14:eabn8543. doi: 10.1126/scitranslmed.abn8543</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abn8543</ArticleId><ArticleId IdType="pmc">PMC8995032</ArticleId><ArticleId IdType="pubmed">35380448</ArticleId></ArticleIdList></Reference><Reference><Citation>Magaret CA, Li L, deCamp AC. et al. Quantifying how single dose Ad26.COV2.S vaccine efficacy depends on spike sequence features. Nat Commun 2024;15:1–22. doi: 10.1038/s41467-024-46536-w</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-024-46536-w</ArticleId><ArticleId IdType="pmc">PMC10928100</ArticleId><ArticleId IdType="pubmed">38467646</ArticleId></ArticleIdList></Reference><Reference><Citation>Marques AD, Sherrill-Mix S, Everett JK. et al. SARS-CoV-2 variants associated with vaccine breakthrough in the Delaware valley through summer 2021. mBio 2021;13:e0378821. doi: 10.1128/mbio.03788-21</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/mbio.03788-21</ArticleId><ArticleId IdType="pmc">PMC8942461</ArticleId><ArticleId IdType="pubmed">35130727</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin DP, Weaver S, Tegally H. et al. The emergence and ongoing convergent evolution of the SARS-CoV-2 N501Y lineages. Cell 2021;184:5189–200.e7. doi: 10.1016/j.cell.2021.09.003</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.09.003</ArticleId><ArticleId IdType="pmc">PMC8421097</ArticleId><ArticleId IdType="pubmed">34537136</ArticleId></ArticleIdList></Reference><Reference><Citation>Mascola JR, Graham BS, Fauci AS. SARS-CoV-2 viral variants—tackling a moving target. JAMA 2021;325:1261–62. doi: 10.1001/jama.2021.2088</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2021.2088</ArticleId><ArticleId IdType="pubmed">33571363</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen L-T, Schmidt HA, von Haeseler A. et al. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol 2014;32:268–74. doi: 10.1093/molbev/msu300</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/msu300</ArticleId><ArticleId IdType="pmc">PMC4271533</ArticleId><ArticleId IdType="pubmed">25371430</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Toole Á, Scher E, Underwood A. et al. Assignment of epidemiological lineages in an emerging pandemic using the pangolin tool. Virus Evol 2021;7:1–9. doi: 10.1093/ve/veab064</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ve/veab064</ArticleId><ArticleId IdType="pmc">PMC8344591</ArticleId><ArticleId IdType="pubmed">34527285</ArticleId></ArticleIdList></Reference><Reference><Citation>Paradis E, Claude J, Strimmer K. et al. APE: analyses of phylogenetics and evolution in R language. Bioinformatics 2004;20:289–90. doi: 10.1093/bioinformatics/btg412</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btg412</ArticleId><ArticleId IdType="pubmed">14734327</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard SA, Epsi NJ, Lindholm DA. et al. COVID-19 patient-reported symptoms using FLU-PRO Plus in a cohort study: associations with infecting genotype, vaccine history, and return to health. Open Forum Infect Dis 2022;9:ofac275. doi: 10.1093/ofid/ofac275</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofac275</ArticleId><ArticleId IdType="pmc">PMC9214183</ArticleId><ArticleId IdType="pubmed">35873301</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard SA, Pollett SD, Fries AC. et al. Persistent COVID-19 symptoms at 6 months after onset and the role of vaccination before or after SARS-CoV-2 infection. JAMA Netw Open 2023;6:e2251360. doi: 10.1001/jamanetworkopen.2022.51360</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2022.51360</ArticleId><ArticleId IdType="pmc">PMC9857077</ArticleId><ArticleId IdType="pubmed">36652247</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard SA, Pollett SD, Lanteri CA. et al. COVID-19 outcomes among US Military Health System beneficiaries include complications across multiple organ systems and substantial functional impairment. Open Forum Infect Dis 2021;8:ofab556. doi: 10.1093/ofid/ofab556</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab556</ArticleId><ArticleId IdType="pmc">PMC8664684</ArticleId><ArticleId IdType="pubmed">34909439</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolland M, and Gilbert PB. Sieve analysis to understand how SARS-CoV-2 diversity can impact vaccine protection. PLoS Pathog 2021;17:e1009406. doi: 10.1371/journal.ppat.1009406</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1009406</ArticleId><ArticleId IdType="pmc">PMC7993616</ArticleId><ArticleId IdType="pubmed">33765086</ArticleId></ArticleIdList></Reference><Reference><Citation>Rolland M, Tovanabutra S, DeCamp AC. et al. Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial. Nat Med 2011;17:366–71. doi: 10.1038/nm.2316.Genetic</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2316.Genetic</ArticleId><ArticleId IdType="pmc">PMC3053571</ArticleId><ArticleId IdType="pubmed">21358627</ArticleId></ArticleIdList></Reference><Reference><Citation>Soubrier J, Steel M, Lee MSY. et al. The influence of rate heterogeneity among sites on the time dependence of molecular rates. Mol Biol Evol 2012;29:3345–58. doi: 10.1093/molbev/mss140</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/molbev/mss140</ArticleId><ArticleId IdType="pubmed">22617951</ArticleId></ArticleIdList></Reference><Reference><Citation>Starr TN, Greaney AJ, Addetia A. et al. Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science 2021;371:850–54. doi: 10.1126/science.abf9302</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf9302</ArticleId><ArticleId IdType="pmc">PMC7963219</ArticleId><ArticleId IdType="pubmed">33495308</ArticleId></ArticleIdList></Reference><Reference><Citation>Tartof SY, Slezak JM, Fischer H. et al. Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study. Lancet 2021;398:1407–16. doi: 10.1016/S0140-6736(21)02183-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)02183-8</ArticleId><ArticleId IdType="pmc">PMC8489881</ArticleId><ArticleId IdType="pubmed">34619098</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson MG, Burgess JL, Naleway AL. et al. Interim estimates of vaccine effectiveness of BNT162b2 and mRNA-1273 COVID-19 vaccines in preventing SARS-CoV-2 infection among health care personnel, first responders, and other essential and frontline workers—eight U.S. locations, December 2020–March 2011. MMWR Morb Mortal Wkly Rep 2021;70:495–500. doi: 10.15585/mmwr.mm7013e3</Citation><ArticleIdList><ArticleId IdType="doi">10.15585/mmwr.mm7013e3</ArticleId><ArticleId IdType="pmc">PMC8022879</ArticleId><ArticleId IdType="pubmed">33793460</ArticleId></ArticleIdList></Reference><Reference><Citation>Valério M, Borges-Araújo L, Melo MN. et al. SARS-CoV-2 variants impact RBD conformational dynamics and ACE2 accessibility. Front Med Technol 2022;4:1–13. doi: 10.3389/fmedt.2022.1009451</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmedt.2022.1009451</ArticleId><ArticleId IdType="pmc">PMC9581196</ArticleId><ArticleId IdType="pubmed">36277437</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W, Lusvarghi S, Subramanian R. et al. Antigenic cartography of well-characterized human sera shows SARS-CoV-2 neutralization differences based on infection and vaccination history. Cell Host Microbe 2022;30:1745–1758.E7. doi: 10.1016/j.chom.2022.10.012</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2022.10.012</ArticleId><ArticleId IdType="pmc">PMC9584854</ArticleId><ArticleId IdType="pubmed">36356586</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Z. A space-time process model for the evolution of DNA sequences. Genetics 1995;139:993–1005. doi: 10.1093/genetics/139.2.993</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/genetics/139.2.993</ArticleId><ArticleId IdType="pmc">PMC1206396</ArticleId><ArticleId IdType="pubmed">7713447</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu G, Smith DK, Zhu H. et al. ggtree: an R package for visualization and annotation of phylogenetic trees with their covariates and other associated data. Methods Ecol Evol 2017;8:28–36. doi: 10.1111/2041-210X.12628</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/2041-210X.12628</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>